Versant Capital Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.57K | Hold |
310
| – | – | ﹤0.01% | 2511 |
|
|
2026
Q2 | $3.29K | Buy |
310
+51
| +20% | +$588 | ﹤0.01% | 2505 |
|
|
2026
Q1 | $2.64K | Sell |
259
-1,130
| -81% | -$12.2K | ﹤0.01% | 2519 |
|
|
2025
Q4 | $14.8K | Sell |
1,389
-29
| -2% | -$347 | ﹤0.01% | 1814 |
|
|
2025
Q3 | $19.4K | Sell |
1,418
-233
| -14% | -$3.25K | ﹤0.01% | 1598 |
|
|
2025
Q2 | $23.2K | Buy |
1,651
+1,029
| +165% | +$13.5K | ﹤0.01% | 1439 |
|
|
2025
Q1 | $8.38K | Buy |
622
+90
| +17% | +$1.35K | ﹤0.01% | 1806 |
|
|
2024
Q4 | $9.37K | Buy |
+532
| New | +$9.87K | ﹤0.01% | 1435 |
|
|
2024
Q2 | – | Sell |
-23
| Closed | -$881 | – | 1981 |
|
|
2024
Q1 | $881 | Buy |
23
+20
| +667% | +$969 | ﹤0.01% | 1571 |
|
|
2023
Q4 | $202 | Sell |
3
-6
| -67% | -$418 | ﹤0.01% | 1865 |
|
|
2023
Q3 | $674 | Sell |
9
-23
| -72% | -$2.04K | ﹤0.01% | 1643 |
|
|
2023
Q2 | $2.95K | Buy |
32
+22
| +220% | +$1.96K | ﹤0.01% | 1228 |
|
|
2023
Q1 | $1.04K | Buy |
+10
| New | +$1.11K | ﹤0.01% | 1431 |
|
|
2019
Q2 | – | Sell |
-11
| Closed | -$1K | – | 1586 |
|
|
2019
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 1458 |
|
|
2018
Q4 | $1K | Sell |
11
-8
| -42% | -$1.37K | ﹤0.01% | 1373 |
|
|
2018
Q3 | $4K | Hold |
19
| – | – | ﹤0.01% | 1154 |
|
|
2018
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 1218 |
|
|
2018
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 1388 |
|
|
2017
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 1433 |
|
|
2017
Q3 | $1K | Sell |
19
-28
| -60% | -$1.39K | ﹤0.01% | 1351 |
|
|
2017
Q2 | $1K | Hold |
47
| – | – | ﹤0.01% | 1347 |
|
|
2017
Q1 | $2K | Hold |
47
| – | – | ﹤0.01% | 1239 |
|
|
2016
Q4 | $1K | Hold |
47
| – | – | ﹤0.01% | 1303 |
|
|
2016
Q3 | $1K | Hold |
47
| – | – | ﹤0.01% | 1290 |
|
|
2016
Q2 | $1K | Buy |
+47
| New | +$1.52K | ﹤0.01% | 1259 |
|
|
2016
Q1 | – | Sell |
-193
| Closed | -$5K | – | 1397 |
|
|
2015
Q4 | $5K | Buy |
+193
| New | +$5.75K | ﹤0.01% | 939 |
|
Other funds holding MED
Versant Capital Management's MED Position: Q3 2026 in Review
Versant Capital Management held its Medifast (MED) position steady in Q3 2026 at 310 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #2511.
Versant Capital Management first reported a position in MED in Q4 2015 and has held it in 26 quarters since. The position peaked at $23.2K in Q2 2025. 4 funds tracked by Wall St. Rank hold MED as of Q3 2026.
- Versant Capital Management held 310 shares of Medifast worth $3.57K as of Q3 2026.
- Versant Capital Management left its Medifast share count unchanged in Q3 2026.
- Medifast made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2511 holding.
- Versant Capital Management first reported a position in Medifast in Q4 2015 and has held it in 26 quarters since.
- Versant Capital Management's Medifast position peaked at $23.2K in Q2 2025.
- 4 funds tracked by Wall St. Rank held Medifast as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.